YPR076W Antibody

What is YPR076W and why are antibodies against it used in research?

YPR076W refers to a putative uncharacterized protein found in Saccharomyces cerevisiae (strain 204508/S288c), commonly known as baker's yeast. This designation follows the systematic nomenclature for S. cerevisiae open reading frames, where YPR indicates its location on chromosome XVI. Despite being uncharacterized, antibodies against this protein serve as important tools for studying protein expression, localization, and function in yeast cell biology. Researchers use these antibodies to investigate fundamental aspects of yeast physiology, cellular processes, and potential homologous proteins in other organisms. The antibody enables detection, quantification, and isolation of the target protein through various immunological techniques, providing insights into its biological role and interactions within cellular pathways .

What are the typical characteristics of YPR076W Antibody?

The commercially available YPR076W antibody is typically a polyclonal antibody raised in rabbits against the Saccharomyces cerevisiae strain 204508/S288c (Baker's yeast). Its key characteristics include:

• Antibody Type: Polyclonal IgG

• Host Species: Rabbit

• Target Specificity: Saccharomyces cerevisiae YPR076W protein

• Purification Method: Antigen-affinity purification, ensuring high specificity

• Applications: Validated for ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot techniques

• Alternative Names: Sometimes referred to as "Putative uncharacterized protein YPR076W Antibody" or "YPR076W P9513.9A"

These characteristics make the antibody suitable for various research applications focused on yeast protein expression and function. The polyclonal nature provides recognition of multiple epitopes on the target protein, potentially increasing detection sensitivity compared to monoclonal antibodies.

How do expression systems affect the production of antibodies against yeast proteins like YPR076W?

The choice of expression system significantly impacts antibody production against yeast proteins like YPR076W. While bacterial systems (E. coli) offer simplicity and high yield, they lack post-translational modifications essential for proper protein folding and epitope presentation. For yeast proteins, eukaryotic expression systems provide advantages but also present challenges:

Saccharomyces cerevisiae as an expression system produces extensively mannosylated N-glycans that are unsuitable for therapeutic antibodies due to rapid clearance in circulation. This hyperglycosylation may affect antibody recognition and function. Yeast-expressed proteins often contain oligomannose N-glycans that differ significantly from mammalian glycosylation patterns .

Mammalian cell expression systems (like CHO cells) provide proper folding and post-translational modifications but at higher cost and lower yield. For research-grade antibodies against yeast proteins, rabbit immunization with purified recombinant protein remains a common approach, as it generates polyclonal antibodies recognizing multiple epitopes .

Recent advances have created modified Saccharomyces cerevisiae strains expressing endoglycosidases (like EndoS2) that can produce proteins with truncated N-glycans consisting of a single N-acetylglucosamine residue. This approach combines the advantages of yeast expression with improved glycosylation profiles, potentially enhancing antibody quality for research applications .

How can researchers validate the specificity of YPR076W Antibody in their experimental systems?

Validating antibody specificity is crucial for obtaining reliable results, especially when working with putative uncharacterized proteins like YPR076W. A comprehensive validation approach should include:

1. Western Blot Analysis with Positive and Negative Controls:

• Positive control: Recombinant YPR076W protein or lysate from wild-type yeast

• Negative control: Lysate from YPR076W knockout strains

• Expected outcome: Single band of appropriate molecular weight in positive control; absence in negative control

2. Epitope Competition Assay:

• Pre-incubate antibody with purified recombinant YPR076W protein

• Apply to Western blot or immunostaining

• Expected outcome: Significant reduction in signal intensity

3. Immunoprecipitation followed by Mass Spectrometry:

• Perform IP using the YPR076W antibody

• Analyze precipitated proteins by mass spectrometry

• Expected outcome: YPR076W should be among the most abundant proteins identified

4. Genetic Validation using Tagged Constructs:

• Express epitope-tagged YPR076W (e.g., with FLAG or HA tag)

• Perform parallel detection with both YPR076W antibody and anti-tag antibody

• Expected outcome: Co-localization of signals

For flow cytometry applications, researchers should validate surface expression by comparing signals between induced and non-induced cells, as described in the literature for yeast surface display systems expressing antibody fragments .

What are the challenges in studying glycoengineered antibodies in Saccharomyces cerevisiae and how do they relate to YPR076W research?

Glycoengineering antibodies in Saccharomyces cerevisiae presents several challenges that may impact YPR076W antibody research:

1. Native Glycosylation Pattern Issues:
Saccharomyces cerevisiae naturally produces extensively mannosylated N-glycans that differ significantly from mammalian glycosylation patterns. These hyperglycosylated structures can affect antibody folding, function, and recognition of target epitopes. For YPR076W antibody production, this could impact epitope accessibility and antibody specificity .

2. Competing Glycosylation Pathways:
Even in glycoengineered yeast strains, competing mannosyltransferases in the Golgi can lead to undesirable glycoforms and lower amounts of the desired glycoform. This heterogeneity complicates quality control and reproducibility in antibody production .

3. Enzymatic Remodeling Requirements:
To overcome natural yeast glycosylation, approaches using endoglycosidases like EndoS2 can be employed to cleave N-glycans, leaving a single N-acetylglucosamine residue. This approach has been successful in producing antibodies with more homogeneous glycosylation profiles .

4. Surface Display Limitations:
For yeast surface display applications using YPR076W antibodies, proper folding and accessibility of target epitopes on the yeast surface require optimization. The creation of specialized strains like EBY100-EndoS2 that can modify the IgG1 Fc domain with a truncated N-glycan has improved these systems .

Understanding these challenges is critical when using YPR076W antibodies for studying protein-protein interactions, particularly if the research involves glycosylated proteins or membrane-associated complexes.

How can flow cytometry be optimized for experiments using YPR076W Antibody in yeast systems?

Optimizing flow cytometry for YPR076W antibody applications in yeast systems requires careful consideration of several factors:

Yeast Cell Preparation Protocol:

• Culture cells in appropriate medium (e.g., YNB-Dropout with 2% glucose for growth, followed by YNB-Dropout with 2% galactose for protein induction)

• Harvest approximately 10^6 cells after 24 hours of induction at 30°C

• Wash cells with 1× PBS followed by 1× PBSA (PBS + 1% Bovine Serum Albumin) to reduce non-specific binding

• Fix cells if needed (with 2-4% paraformaldehyde for 15-30 minutes) for intracellular proteins

Antibody Staining Optimization:

• Incubate washed yeast cells with primary YPR076W antibody on ice for 45-60 minutes in the dark

• Use appropriate antibody dilution (typically 1:100 to 1:1000) in PBSA

• Wash with PBSA to remove unbound antibody

• Incubate with fluorophore-conjugated secondary antibody (e.g., phycoerythrin-conjugated anti-rabbit IgG) on ice for 45-60 minutes

• Perform final washes with PBS before analysis

Controls and Validation:

• Include unstained cells to establish baseline autofluorescence

• Include secondary-only controls to assess non-specific binding

• Use YPR076W knockout strains as negative controls

• Consider using GFP-tagged YPR076W constructs as positive controls for co-localization studies

• Validate results using alternative methods such as Western blotting

These protocols have been successfully used for studying antibody fragments displayed on yeast surfaces and can be adapted for YPR076W antibody applications in both surface and intracellular detection scenarios.

What are the optimal protocols for using YPR076W Antibody in Western Blot analyses?

For optimal Western Blot results with YPR076W antibody, researchers should follow this detailed protocol:

Sample Preparation:

• Harvest yeast cells at appropriate growth phase (typically mid-log)

• Prepare cell lysates using mechanical disruption (glass beads) or enzymatic lysis (e.g., zymolyase treatment)

• Include protease inhibitors to prevent protein degradation

• Determine protein concentration using Bradford or BCA assay

• Prepare samples in 2× SDS PAGE sample buffer with reducing agent

Gel Electrophoresis and Transfer:

• Load 10-20 μg of total protein per lane

• Use 12% SDS-polyacrylamide gel for optimal resolution

• Include molecular weight markers

• Transfer proteins to PVDF membrane using standard transfer conditions (e.g., Invitrogen Power Blotter)

Blocking and Antibody Incubation:

• Block membrane in TBST with 5% dry milk for one hour at room temperature

• Incubate with rabbit anti-YPR076W primary antibody (1:1000 dilution) in 5% dry milk in TBST overnight at 4°C

• Wash three times for 5 minutes with TBST buffer

• Incubate with HRP-conjugated anti-rabbit secondary antibody (1:2000 dilution) in 5% milk in TBST for 2 hours at room temperature

• Wash three times with TBST for 5 minutes each

Detection and Analysis:

• Apply ECL Western Blotting Substrate

• Image using an appropriate system (e.g., ChemiDoc XRS+)

• Quantify signal intensity relative to loading controls

• Expected result: A specific band corresponding to YPR076W protein

This protocol has been validated for detection of yeast-expressed proteins and should provide reliable results for YPR076W detection in appropriate samples.

How can YPR076W Antibody be used in combination with glycoprotein analysis techniques?

YPR076W antibody can be effectively combined with glycoprotein analysis techniques to study protein glycosylation and function. Here are methodological approaches for such integrated analyses:

Immunoprecipitation Followed by Glycan Analysis:

• Use YPR076W antibody to immunoprecipitate the target protein from yeast lysates

• Elute the protein and verify successful IP by Western blot

• For glycan analysis, digest the purified protein with trypsin (approximately 1.8 μg) at 37°C overnight

• Lyophilize the digest and resuspend in binding buffer (15 mM ammonium acetate, 85% acetonitrile, pH 3.5)

• Load the sample onto a Cellulose/HILIC column

• Wash with binding solution (3 × 10 μL)

• Elute glycopeptides with 15 mM ammonium acetate, 10% acetonitrile, pH 3.5

• Analyze eluted fractions by mass spectrometry to characterize glycan structures

Enzymatic Deglycosylation Analysis:

• Treat immunoprecipitated YPR076W with endoglycosidases like EndoH, PNGase F, or EndoS2

• Compare migration patterns of treated and untreated samples by Western blot

• Changes in molecular weight can indicate the presence and extent of glycosylation

• This approach can reveal whether glycosylation affects antibody recognition of the target protein

Lectin Blotting in Parallel with YPR076W Immunoblotting:

• Prepare duplicate blots of the same samples

• Probe one blot with YPR076W antibody

• Probe the second blot with relevant lectins (e.g., ConA for mannose structures)

• Compare binding patterns to correlate protein identity with glycosylation state

These approaches leverage the specificity of YPR076W antibody with the analytical power of glycobiology techniques, providing insights into both protein expression and post-translational modifications.

What troubleshooting approaches should be used for common issues with YPR076W Antibody experiments?

When working with YPR076W antibody, researchers may encounter various challenges. Here are systematic troubleshooting approaches for common issues:

Issue 1: Weak or No Signal in Western Blot

Methodological Solutions:

• Increase primary antibody concentration (try 1:500 instead of 1:1000)

• Extend primary antibody incubation time (overnight at 4°C)

• Use more sensitive detection reagents (e.g., enhanced chemiluminescence substrate)

• Increase protein loading (25-50 μg instead of 10-20 μg)

• Verify protein transfer efficiency with Ponceau S staining

• Check if denaturation conditions affect epitope recognition; try native conditions

• Evaluate if target protein is low abundance; consider enrichment steps

Issue 2: High Background or Non-specific Bands

Methodological Solutions:

• Increase blocking stringency (5-10% milk/BSA, longer blocking time)

• Use more stringent washing conditions (increase wash buffer volume and time)

• Dilute primary antibody further (1:2000 or 1:5000)

• Pre-absorb antibody with cell lysate from YPR076W knockout strain

• Reduce secondary antibody concentration

• Try alternative blocking agents (e.g., BSA instead of milk)

• Optimize incubation temperature (4°C may reduce non-specific binding)

Issue 3: Inconsistent Results in Flow Cytometry

Methodological Solutions:

• Standardize cell fixation and permeabilization protocols

• Use freshly prepared reagents and cells

• Include unstained and single-stained controls for compensation

• Standardize collection of specific number of events (minimum 10,000 cells)

• Optimize fluorophore selection to avoid spectral overlap

• Consider using directly conjugated primary antibody to reduce steps

• Verify protein expression conditions (check galactose induction timing)

Issue 4: Failed Immunoprecipitation

Methodological Solutions:

• Check antibody-bead coupling efficiency

• Increase antibody amount or lysate incubation time

• Modify lysis buffer composition to preserve protein-antibody interaction

• Ensure proper lysis conditions to release target protein

• Pre-clear lysate to reduce non-specific binding

• Verify if detergents in lysis buffer are compatible with antibody binding

• Consider cross-linking approach if interaction is transient

These methodological approaches address the most common technical challenges encountered when using YPR076W antibody in various experimental contexts.

How can the YPR076W Antibody be utilized in yeast surface display techniques?

Yeast surface display is a powerful technique for protein engineering and studying protein-protein interactions. The YPR076W antibody can be effectively integrated into these systems using the following methodological approach:

Experimental Setup for Yeast Surface Display:

• Transform EBY100 or similar display-competent yeast strains with appropriate YPR076W display constructs

• Include appropriate control constructs (empty vector, known binding partners)

• Culture transformed yeast in YNB-Dropout medium with 2% glucose for growth

• Induce protein expression by transferring to YNB-Dropout with 2% galactose for 24 hours at 30°C

• Harvest approximately 10^6 cells for surface display analysis

Detection and Analysis Protocol:

• Wash harvested cells with PBS and PBSA to reduce background

• Incubate with YPR076W antibody (1:100 to 1:500 dilution) on ice for 45-60 minutes in the dark

• Wash with PBSA to remove unbound antibody

• Incubate with fluorophore-conjugated secondary antibody on ice for 45-60 minutes

• Analyze by flow cytometry to quantify surface expression levels

• For interaction studies, co-stain with fluorescently labeled binding partners

This approach has been successfully implemented for studying IgG1 Fc fragments on yeast surfaces and can be adapted for YPR076W studies. The technique allows for quantitative assessment of protein expression levels and binding interactions in a cellular context, providing advantages over in vitro systems.

Research has demonstrated that yeast surface display can be combined with glycoengineering approaches, such as incorporating EndoS2 expression, to modify displayed proteins with specific glycosylation patterns that enhance binding and recognition properties .

What role can YPR076W Antibody play in understanding uncharacterized yeast protein functions?

The YPR076W antibody represents a valuable tool for elucidating the functions of this putative uncharacterized protein through multiple experimental approaches:

Protein Localization Studies:

• Use immunofluorescence microscopy with YPR076W antibody to determine subcellular localization

• Compare localization patterns under different growth conditions and stress responses

• Co-localize with known organelle markers to establish cellular context

• Changes in localization can provide clues to protein function and regulation

Protein-Protein Interaction Networks:

• Employ co-immunoprecipitation with YPR076W antibody followed by mass spectrometry

• Identify binding partners under different physiological conditions

• Validate interactions using reciprocal co-IP or proximity labeling techniques

• Construct interaction networks to place YPR076W in cellular pathways

Expression Profiling:

• Use Western blotting with YPR076W antibody to quantify expression levels

• Compare expression across growth phases, stress conditions, and genetic backgrounds

• Correlate expression patterns with known cellular processes

• Identify conditions that regulate YPR076W expression

Functional Genomics Integration:

• Combine antibody-based detection with phenotypic analysis of YPR076W mutants

• Correlate protein levels with phenotypic outcomes

• Use the antibody to validate genetic screen results

• Integrate data with existing genomic and proteomic datasets

These multifaceted approaches leverage the specificity of the YPR076W antibody to generate comprehensive insights into the function of this uncharacterized protein, potentially revealing new aspects of yeast biology and cellular processes applicable to broader eukaryotic systems.